posted on 2023-10-09, 17:35authored byYacoba
V. T. Minnow, Vern L. Schramm, Steven C. Almo, Agnidipta Ghosh
Purine nucleoside phosphorylases (PNPs) catalyze the
phosphorolysis
of 6-oxypurine nucleosides with an HPO<sub>4</sub><sup>2–</sup> dianion nucleophile. Nucleosides and phosphate occupy distinct pockets
in the PNP active site. Evaluation of the HPO<sub>4</sub><sup>2–</sup> site by mutagenesis, cooperative binding studies, and thermodynamic
and structural analysis demonstrate that alterations in the HPO<sub>4</sub><sup>2–</sup> binding site can render PNP inactive
and significantly impact subunit cooperativity and binding to transition-state
analogue inhibitors. Cooperative interactions between the cationic
transition-state analogue and the anionic HPO<sub>4</sub><sup>2–</sup> nucleophile demonstrate the importance of reforming the transition-state
ensemble for optimal inhibition with transition-state analogues. Altered
phosphate binding in the catalytic site mutants helps to explain one
of the known lethal PNP deficiency syndromes in humans.